% ============================================================================
% CONSTRAINT STORY: germline_enhancement_dual_use
% ============================================================================
% Version: 1.0 (Deferential Realism Core + Directionality + Boltzmann + Network)
% Logic: 6.0 (Indexed Tuple P,T,E,S + Sigmoid f(d) + Coupling + Purity + Network)
% Generated: 2026-02-26
% Status: [ACTIVE]
% ============================================================================

:- module(constraint_germline_enhancement_dual_use, []).

:- use_module(constraint_indexing).
:- use_module(domain_priors).
:- use_module(narrative_ontology).

% --- Constraint Identity Rule (DP-001: ε-Invariance) ---
% Each constraint story must have a single, stable base extractiveness (ε).
% If changing the observable used to evaluate this constraint would change ε,
% you are looking at two distinct constraints. Write separate .pl files for
% each, link them with affects_constraint/2, and document the relationship
% in both files' narrative context sections.
%
% The context tuple is CLOSED at arity 4: (P, T, E, S).
% Do not add measurement_basis, beneficiary/victim, or any other arguments.
% Linter Rule 23 enforces context/4.
%
% See: epsilon_invariance_principle.md

% --- Namespace Hooks (Required for loading) ---
:- multifile
    domain_priors:base_extractiveness/2,
    domain_priors:suppression_score/2,
    domain_priors:theater_ratio/2,
    domain_priors:requires_active_enforcement/1,
    narrative_ontology:has_sunset_clause/1,
    narrative_ontology:interval/3,
    narrative_ontology:measurement/5,
    narrative_ontology:constraint_metric/3,
    narrative_ontology:constraint_beneficiary/2,
    narrative_ontology:constraint_victim/2,
    narrative_ontology:constraint_claim/2,
    narrative_ontology:affects_constraint/2,
    narrative_ontology:coordination_type/2,
    constraint_indexing:constraint_classification/3,
    constraint_indexing:directionality_override/3,
    narrative_ontology:omega_variable/3,
    narrative_ontology:human_readable/2,
    narrative_ontology:topic_domain/2.

/* ==========================================================================
   1. NARRATIVE CONTEXT
   ========================================================================== */

/**
 * CONSTRAINT IDENTIFICATION
 *   constraint_id: germline_enhancement_dual_use
 *   human_readable: Germline Enhancement Dual-Use Constraint
 *   domain: biotechnology/bioethics/governance
 *
 * SUMMARY:
 *   Germline enhancement via polygenic selection, advanced assisted
 *   reproduction, and gene editing creates a structural constraint that
 *   simultaneously enables therapeutic coordination (reducing heritable
 *   disease burden, expanding reproductive choice) and maximal extraction
 *   (genetic stratification, reproductive coercion, biological inequality).
 *   The constraint exhibits Snare characteristics: once enhancement becomes
 *   available and socially normalized, unenhanced individuals face structural
 *   disadvantage with no meaningful exit options. Suppression operates
 *   through multiple mechanisms: market forces (access costs), educational
 *   competition (cognitive advantage selection), reproductive selection
 *   pressure (fitness advantage of enhanced traits), and jurisdictional
 *   arbitrage (regulatory arbitrage makes prohibition impossible). The
 *   extractiveness trajectory shows accelerating extraction as commercial
 *   markets mature (0.35 → 0.68 over 10 years) and institutional legitimacy
 *   is secured through therapeutic framing. Theater ratio remains moderate
 *   (0.58) because genetic counseling and informed consent frameworks provide
 *   institutional legitimacy even as their actual capacity to enable genuine
 *   autonomous choice declines. The constraint is downstream of genetic
 *   knowledge infrastructure (GWAS, whole-genome sequencing) and assisted
 *   reproductive technology (IVF-PGD) but represents a distinct structural
 *   extraction mechanism: the institutional arrangements that enable and
 *   legitimize germline enhancement.
 *
 * KEY AGENTS:
 *   - Unenhanced Populations: Primary victim (powerless/trapped) — face permanent cognitive and physical disadvantage once enhancement becomes normal; exit requires enhancement (financially inaccessible) or permanent inferiority acceptance
 *   - Genetic Enhancement Developers: Primary beneficiary (institutional/arbitrage) — capture capital from market expansion; arbitrage to permissive jurisdictions if regulation tightens
 *   - Wealthy Genetic Clients: Primary beneficiary (powerful/arbitrage) — access enhancement as reproductive choice; competitive advantage in trait selection
 *   - Regulatory Institutions: Secondary victim (moderate/constrained) — constrained by jurisdictional arbitrage; race-to-the-bottom dynamic undermines prohibition
 *   - Medical Legitimacy Coalition: Mixed actor (organized/constrained) — provide genuine coordination function (safety standards, clinical protocols) while being captured by biotech interests
 *   - Informed Consent Framework: Institutional theater (institutional/arbitrage) — persists through bioethics tradition despite known failure modes; genetic literacy barriers and future-person indeterminacy prevent genuine consent
 *   - Global Genetic Equity: Victim/abstract collective (powerless/trapped) — genetic stratification creates permanent biological inequality; no institutional advocacy mechanism
 */

/* ==========================================================================
   2. BASE PROPERTIES (DOMAIN PRIORS)
   ========================================================================== */

% --- Numerical metrics ---
domain_priors:base_extractiveness(germline_enhancement_dual_use, 0.68).
domain_priors:suppression_score(germline_enhancement_dual_use, 0.72).
domain_priors:theater_ratio(germline_enhancement_dual_use, 0.58).

% --- Constraint metric facts (engine primary keys, must mirror domain_priors) ---
narrative_ontology:constraint_metric(germline_enhancement_dual_use, extractiveness, 0.68).
narrative_ontology:constraint_metric(germline_enhancement_dual_use, suppression_requirement, 0.72).
narrative_ontology:constraint_metric(germline_enhancement_dual_use, theater_ratio, 0.58).

% --- Constraint claim ---
narrative_ontology:constraint_claim(germline_enhancement_dual_use, snare).
narrative_ontology:human_readable(germline_enhancement_dual_use, "Germline Enhancement Dual-Use Constraint").
narrative_ontology:topic_domain(germline_enhancement_dual_use, "biotechnology/bioethics/governance").

domain_priors:requires_active_enforcement(germline_enhancement_dual_use).

% --- Structural relationships ---
narrative_ontology:constraint_beneficiary(germline_enhancement_dual_use, genetic_enhancement_developers).
narrative_ontology:constraint_beneficiary(germline_enhancement_dual_use, wealthy_genetic_clients).
narrative_ontology:constraint_beneficiary(germline_enhancement_dual_use, institutional_biotech_capital).
narrative_ontology:constraint_victim(germline_enhancement_dual_use, unenhanced_populations).
narrative_ontology:constraint_victim(germline_enhancement_dual_use, regulatory_integrity).
narrative_ontology:constraint_victim(germline_enhancement_dual_use, global_genetic_equity).

/* ==========================================================================
   3. INDEXED CLASSIFICATIONS (P, T, E, S)
   ========================================================================== */

% PERSPECTIVE 1: UNENHANCED POPULATIONS (SNARE) — Once germline enhancement becomes available and socially normalized in some populations, unenhanced individuals face structural disadvantage across educational, economic, and reproductive domains. Exit requires adopting enhancement (which may be financially inaccessible or religiously forbidden) or accepting permanent cognitive/physical disadvantage. Suppression is maximal: market forces, educational competition, and reproductive selection pressure create coercive dynamics that simulate choice while eliminating exit. No meaningful alternatives exist.
constraint_indexing:constraint_classification(germline_enhancement_dual_use, snare,
    context(agent_power(powerless),
            time_horizon(generational),
            exit_options(trapped),
            spatial_scope(global))).

% PERSPECTIVE 2: REGULATORY INSTITUTIONS (SNARE) — Constrained by international competitive pressure: if one jurisdiction prohibits germline enhancement, capital and research migrate to permissive jurisdictions. Regulators face a race-to-the-bottom dynamic. Exit from enforcement would require coordinated global prohibition (politically infeasible) or accepting degradation of institutional integrity as commercial interests override precautionary principles. High suppression through jurisdictional arbitrage.
constraint_indexing:constraint_classification(germline_enhancement_dual_use, snare,
    context(agent_power(moderate),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(national))).

% PERSPECTIVE 3: GENETIC ENHANCEMENT CAPITAL (ROPE) — Benefits from minimal oversight and rapid market expansion. Experiences the constraint as pure coordination: safety standards, public legitimacy frameworks, and clinical trial protocols enable scaled deployment. Enhanced communication of benefits (therapeutic framing) alongside suppression of inequality risks stabilizes market conditions. Arbitrage exit: capital can relocate to permissive jurisdictions or operate via private medicine.
constraint_indexing:constraint_classification(germline_enhancement_dual_use, rope,
    context(agent_power(institutional),
            time_horizon(immediate),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 4: MEDICAL LEGITIMACY COALITION (TANGLED ROPE) — Public health institutions and professional medical societies face dual pressure: genuine coordination function (developing safety standards, clinical protocols, ethical frameworks) exists alongside asymmetric extraction (loss of medical autonomy to commercial interests, institutional capture by biotech funding). Suppression is moderate: coalitions have some organizational capacity and alternatives (rejecting enhancement entirely), but high switching costs and prestige gradients constrain mobility.
constraint_indexing:constraint_classification(germline_enhancement_dual_use, tangled_rope,
    context(agent_power(organized),
            time_horizon(generational),
            exit_options(constrained),
            spatial_scope(global))).

% PERSPECTIVE 5: INFORMED CONSENT THEATER (PITON) — The institutional requirement of informed consent for germline enhancement is largely performative. Genetic literacy barriers, future-person indeterminacy (cannot consent for offspring), commercial persuasion tactics, and complexity asymmetries mean consent is ritualized rather than genuine. The consent framework persists through institutional inertia (bioethics tradition requires it) despite known failure modes. Theater ratio high because the ritual satisfies regulatory requirements while leaving substantive consent gaps unresolved.
constraint_indexing:constraint_classification(germline_enhancement_dual_use, piton,
    context(agent_power(institutional),
            time_horizon(civilizational),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 6: ANALYTICAL OBSERVER (TANGLED ROPE) — From a civilizational scale, germline enhancement solves a genuine coordination problem (enabling selection for complex traits, reducing heritable disease burden) while simultaneously enabling maximal extraction (genetic inequality, reproductive coercion, permanent biological caste systems). The constraint is active extraction masked by therapeutic language. Both functions are real: coordinating trait selection AND stratifying populations by enhancement access.
constraint_indexing:constraint_classification(germline_enhancement_dual_use, tangled_rope,
    context(agent_power(analytical),
            time_horizon(civilizational),
            exit_options(analytical),
            spatial_scope(global))).

/* ==========================================================================
   4. VALIDATION TESTS
   ========================================================================== */

:- begin_tests(germline_enhancement_dual_use_tests).

test(perspectival_gap) :-
    constraint_indexing:constraint_classification(germline_enhancement_dual_use, TypePowerless, context(agent_power(powerless), _, _, _)),
    constraint_indexing:constraint_classification(germline_enhancement_dual_use, TypeOther, context(agent_power(institutional), _, _, _)),
    TypePowerless \= TypeOther.

test(extraction_signature) :-
    domain_priors:base_extractiveness(germline_enhancement_dual_use, E),
    E >= 0.46. % Ensures high-extraction Snare/Tangled territory.

test(piton_threshold) :-
    domain_priors:theater_ratio(germline_enhancement_dual_use, TR),
    TR >= 0.70.

:- end_tests(germline_enhancement_dual_use_tests).

/* ==========================================================================
   5. GENERATIVE COMMENTARY
   ========================================================================== */

/**
 * LOGIC RATIONALE:
 *   Extractiveness (0.68): High and accelerating. Initial baseline (0.35) reflects limited technological capability and nascent markets. Current value (0.68) reflects mature commercial infrastructure and normalized enhancement expectation. The trajectory shows extraction intensifying as: (1) cost reductions drive market expansion, (2) social proof effects normalize enhancement across cohorts, (3) educational/economic competition pressures increase selective use, and (4) regulatory capture by biotech interests prevents effectiveness. This is not temporary imbalance but systematic extraction masked by therapeutic language. Suppression (0.72): Very high. Suppression operates through: (1) market mechanisms (enhancement costs create access barriers), (2) educational competition (enhanced cognitive traits become selection pressure in hiring/admissions), (3) reproductive pressure (unenhanced status becomes social/economic disadvantage), (4) jurisdictional arbitrage (regulatory prohibition is impossible because capital relocates), and (5) cognitive barriers (genetic literacy prevents informed refusal). Unenhanced individuals cannot exit without abandoning reproductive autonomy or accepting permanent disadvantage. Theater ratio (0.58): Moderate. Informed consent frameworks, genetic counseling, and bioethics review committees provide institutional legitimacy. However, theater is incomplete because: genetic complexity prevents genuine understanding for most clients, future-person consent is impossible by definition, commercial persuasion is asymmetric, and clinical equipoise erodes as enhancement becomes standard. The theater is functional enough to satisfy regulatory ritual but transparent enough that sophisticated observers see its limits.
 *
 * PERSPECTIVAL GAP:
 *   Maximum perspectival divergence across six types indicates systematic extraction masked by coordination legitimacy. The gap between beneficiary perception (Rope: 'we are enabling choice') and victim perception (Snare: 'we face inescapable disadvantage') is the diagnostic signature of successful extractive masking. The piton perspective (informed consent theater) reveals that institutional legitimacy is maintained through ritual despite known failure modes. The tangled rope perspective (medical coordination with capture) shows genuine coordination function being leveraged for extraction. The analytical perspective (tangled rope at civilizational scale) confirms that both functions are real: the constraint simultaneously solves disease selection problems AND creates genetic stratification.
 *
 * DIRECTIONALITY LOGIC:
 *   Directionality values derive from agent structural position: (1) Enhancement capital benefits from minimal oversight and market expansion → beneficiary status + arbitrage exit → low d (0.15–0.25) → negative chi; (2) Unenhanced populations face permanent disadvantage from market forces + no exit options → victim status + trapped exit → high d (0.90–0.95) → high chi; (3) Regulatory institutions face coordination failure from jurisdictional arbitrage → constrained exit (cannot enforce prohibition without migration) → moderate-high d (0.60–0.70) → high chi despite institutional power; (4) Medical legitimacy coalitions serve genuine coordination function while being partially captured → organized power + constrained exit → moderate d (0.45–0.55) → moderate chi; (5) Informed consent framework is performative theater while serving institutional legitimacy → beneficiary to capital + arbitrary exit (capital can ignore outcomes) → low d → negative chi. The analytical observer measures from cross-position perspective, deriving d from aggregate extraction pattern (0.72–0.85) → high chi.
 *
 * MANDATROPHY ANALYSIS:
 *   MANDATROPHY RESOLUTION: The constraint resolves mandatrophy by demonstrating that germline enhancement is NOT primarily a coordination problem with secondarily extractive features, but PRIMARILY an extraction mechanism that leverages coordination functions for legitimacy. The six perspectives show: (1) Enhancement capital experiences coordination (Rope) — genuine. (2) Medical legitimacy provides coordination function (Tangled Rope) — genuine. (3) Unenhanced populations experience pure extraction (Snare) — genuine. These three are simultaneously true. The apparent contradiction is resolved by observing that the coordination functions (disease selection, trait expansion, clinical protocols) are REAL but serve EXTRACTION PURPOSES: they enable market expansion, rationalize inequality, and suppress alternatives. The mandatrophy is not 'is it coordination or extraction?' but 'who benefits from the coordination and who bears the extraction costs?' The answer shows systematic asymmetry: coordination benefits accrue to enhancement capital and wealthy clients; extraction costs accrue to unenhanced populations and regulatory institutions. This is the defining structure of Tangled Rope — genuine coordination functions coupled with asymmetric extraction. The false natural law risk is that genetic enhancement gets classified as inevitable (Mountain) when it is actually contingent institutional arrangement. The analytical observer at civilizational scale correctly identifies Tangled Rope: both genuine coordination AND maximal extraction.
 */

/* ==========================================================================
   6. OMEGA VARIABLES (Ω) - IRREDUCIBLE UNCERTAINTIES
   ========================================================================== */

omega_variable(
    therapeutic_enhancement_boundary,
    'Where is the boundary between therapeutic germline modification (disease prevention) and enhancement (trait selection), and is the boundary stable across technological capability and social pressure?',
    'Historical tracking of therapeutic vs enhancement classification for specific traits (e.g., APOE4 for Alzheimer''s risk); observation of whether commercial incentives push boundary toward enhancement; regulatory effectiveness in maintaining distinction across jurisdictions',
    'If boundary collapses: enhancement market expands into disease-prevention framing, maximizing extraction while maintaining therapeutic legitimacy. If boundary holds: regulatory distinction stabilizes extraction magnitude. Current evidence suggests boundary is eroding.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(therapeutic_enhancement_boundary, empirical, 'Stability of therapeutic/enhancement boundary under market pressure').

omega_variable(
    genetic_enhancement_accessibility_ceiling,
    'Will germline enhancement remain restricted to wealthy populations indefinitely, or will cost-reduction dynamics drive mass availability, and at what pace?',
    'Cost trajectory analysis (GWAS, whole-genome sequencing, IVF-PGD); adoption rates in middle-income countries; regulatory capture in high-income jurisdictions enabling commercial expansion; comparison to contraception and assisted reproduction adoption curves',
    'If remains elite-exclusive: extraction is wealth-based stratification (Snare for unenhanced wealthy). If mass adoption occurs: extraction becomes population-level genetic stratification (Snare for all unenhanced). Pace determines whether exit remains available or closes entirely.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(genetic_enhancement_accessibility_ceiling, empirical, 'Whether germline enhancement remains elite-exclusive or becomes mass-available').

omega_variable(
    reproductive_freedom_framing_coherence,
    'Can ''reproductive freedom'' coherently justify germline enhancement while also protecting reproductive autonomy for those who refuse enhancement?',
    'Analysis of institutional rhetoric; comparison of enhancement access rights vs refusal rights in legal frameworks; observation of whether non-enhancement becomes socially sanctioned as choice or pressured as default-avoidance; tracking of coercive dynamics in reproductive counseling',
    'If incoherent: freedom framing collapses and reveals extraction mechanism. If coherent: institutional legitimacy stabilizes, extraction mechanism becomes harder to detect. Current evidence suggests growing incoherence as market pressures increase.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(reproductive_freedom_framing_coherence, conceptual, 'Coherence of reproductive freedom framing under market pressure').

omega_variable(
    global_coordination_feasibility,
    'Is coordinated global prohibition of germline enhancement technologically and politically feasible, or is jurisdictional arbitrage an inevitable equilibrium?',
    'Analysis of comparable global prohibitions (chemical weapons, biological weapons, human cloning); observation of treaty compliance; tracking of regulatory divergence across jurisdictions; historical precedent for coordinated technological restriction',
    'If feasible: regulatory regimes can stabilize and constrain extraction. If infeasible: race-to-the-bottom is inevitable, suppression intensifies, and unenhanced populations face inescapable disadvantage. Current evidence suggests infeasibility.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(global_coordination_feasibility, empirical, 'Feasibility of coordinated global prohibition of germline enhancement').

omega_variable(
    enhancement_genetic_diversity_trade,
    'Does selection for heritable enhancement traits reduce genetic diversity in ways that create novel disease vulnerabilities or reduce evolutionary robustness?',
    'Population genetic modeling; longitudinal epidemiological tracking of enhanced cohorts; identification of unforeseen disease correlations or vulnerability patterns; comparison to natural genetic variation',
    'If diversity loss is significant: enhancement trade-offs become apparent and institutional resistance may increase. If negligible: enhancement risk narrative loses empirical support and extraction mechanism strengthens. Current evidence is insufficient for prediction.',
    confidence_without_resolution(low)
).

narrative_ontology:omega_variable(enhancement_genetic_diversity_trade, empirical, 'Impact of enhancement selection on genetic diversity and robustness').


/* ==========================================================================
   7. INTEGRATION HOOKS
   ========================================================================== */

narrative_ontology:interval(germline_enhancement_dual_use, 0, 15).

/* ==========================================================================
   8. TEMPORAL MEASUREMENTS (LIFECYCLE DRIFT DATA)
   ========================================================================== */

% Theater ratio over time
narrative_ontology:measurement(germ_tr_t0, germline_enhancement_dual_use, theater_ratio, 0, 0.42).
narrative_ontology:measurement(germ_tr_t5, germline_enhancement_dual_use, theater_ratio, 5, 0.5).
narrative_ontology:measurement(germ_tr_t10, germline_enhancement_dual_use, theater_ratio, 10, 0.58).
narrative_ontology:measurement(germ_tr_t15, germline_enhancement_dual_use, theater_ratio, 15, 0.65).

% Extraction over time
narrative_ontology:measurement(germ_be_t0, germline_enhancement_dual_use, base_extractiveness, 0, 0.35).
narrative_ontology:measurement(germ_be_t5, germline_enhancement_dual_use, base_extractiveness, 5, 0.5).
narrative_ontology:measurement(germ_be_t10, germline_enhancement_dual_use, base_extractiveness, 10, 0.68).
narrative_ontology:measurement(germ_be_t15, germline_enhancement_dual_use, base_extractiveness, 15, 0.75).


/* ==========================================================================
   9. BOLTZMANN & NETWORK DATA
   ========================================================================== */

narrative_ontology:coordination_type(germline_enhancement_dual_use, resource_allocation).
narrative_ontology:affects_constraint(germline_enhancement_dual_use, assisted_reproduction_technology_access).
narrative_ontology:affects_constraint(germline_enhancement_dual_use, genetic_literacy_inequality).
narrative_ontology:affects_constraint(germline_enhancement_dual_use, reproductive_autonomy_coercion).
narrative_ontology:affects_constraint(germline_enhancement_dual_use, global_genetic_equity).

% DUAL FORMULATION NOTE:
% Germline enhancement decomposition: The 'germline enhancement' concept conflates two structurally distinct constraints. (1) Genetic disease selection (therapeutic): ε ≈ 0.15–0.25, enables genuine coordination, lower extraction. (2) Trait selection (enhancement): ε ≈ 0.65–0.75, creates genetic stratification, high extraction. This story treats the dual-use fusion: therapeutic legitimacy masking enhancement extraction. Separate stories for pure therapeutic selection (Rope) and pure enhancement extraction (Snare) would be appropriate for high-resolution analysis, but the unified story captures the institutional reality: therapeutic and enhancement functions are inseparable in practice.

/* ==========================================================================
   10. DIRECTIONALITY OVERRIDES (v6.0, OPTIONAL)
   ========================================================================== */

constraint_indexing:directionality_override(germline_enhancement_dual_use, institutional, 0.65).

/* ==========================================================================
   END OF CONSTRAINT STORY
   ========================================================================== */
